Xontogeny is a biotech aggregator.
Xontogeny seeks to accelerate the development of life science technologies by providing entrepreneurs with the leadership, strategic guidance and operational support necessary to increase the probability of success in early drug and technology development. Through a differentiated approach, the Xontogeny team partners with the founding scientists and entrepreneurs of new ventures to support their vision while allowing a more efficient development model to benefit company founders and early equity holders.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 18, 2017 | Series A | $15M | 1 | Perceptive Advisors | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 13, 2022
Tellus Therapeutics
|
Series A | $35M | Biotechnology | Yes |
Dec 13, 2022
Peroxitech Therapeutics
|
Series A | $25M | Biopharma | Yes |
Apr 11, 2022
PolyCore Therapeutics
|
Seed | — | Health Care | Yes |
May 12, 2021
Peroxitech Therapeutics
|
Seed | — | Biopharma | Yes |
May 12, 2021
Nephraegis Therapeutics
|
Seed | — | Biopharma | Yes |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Perceptive Advisors | Yes | Series A |